Immediately after administration, S23 binds to the androgen receptor with a really large affinity, and actively competes with Testosterone and DHT for AR activation. A few of these adverse outcomes include things like but are not restricted to benign prostate hyperplasia, prostate carcinoma, acne breakouts, and expedited male pattern baldness. https://sarmsamerica.com/collections/individual-sarms/products/s23?variant=40005879431246